Gurnet Point Capital and Patient Square Capital Acquire Radius Health
June 23, 2022
Gurnet Point Capital and Patient Square Capital completed a take-private acquisition of Radius Health, Inc. in a transaction valued at approximately $890 million (including debt), paying $10.00 per share in cash plus a $1.00 CVR tied to TYMLOS sales. Debt financing was provided by OrbiMed Advisors; following the transaction Radius will be delisted and will remain operating in the Boston, MA and Wayne, PA areas as a privately held biopharmaceutical company focused on bone health and neuro-orphan diseases.
- Buyers
- Gurnet Point Capital, Patient Square Capital
- Targets
- Radius Health, Inc.
- Sellers
- Radius shareholders
- Industry
- Biotechnology
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Gurnet Point Capital and Novo Holdings Acquire Paratek Pharmaceuticals
September 21, 2023
Pharmaceuticals
Gurnet Point Capital and Novo Holdings completed the acquisition of Paratek Pharmaceuticals for $2.15 per share in cash plus a $0.85 CVR tied to NUZYRA sales, in a transaction valued at approximately $462 million including assumed debt. Oaktree provided $175 million of debt financing; following closing Paratek will be taken private and delisted from Nasdaq as the buyers aim to accelerate commercialization of NUZYRA and expand Paratek's anti-infective portfolio.
-
Elliott, Patient Square and Veritas Acquire Syneos Health for ~$7.1B
May 10, 2023
Healthcare Services
A consortium of private investment firms—Elliott Investment Management, Patient Square Capital and Veritas Capital—has completed the acquisition of Syneos Health for $43.00 per share, a transaction valued at approximately $7.1 billion including debt. Syneos Health will become a privately held company, with the new owners planning to accelerate its transformation, invest in technology and strengthen its integrated biopharmaceutical services.
-
Patient Square Capital Acquires Premier, Inc.
November 25, 2025
Healthcare Services
Patient Square Capital, a healthcare-focused private equity firm, is acquiring Premier, Inc. in a take-private transaction approved by Premier stockholders. Under the deal Premier stockholders will receive $28.25 per share (a ~23.8% premium) and the transaction — valued at roughly $2.6 billion — was expected to close on or about November 25, 2025.
-
Patient Square Capital Acquires Patterson Companies
April 17, 2025
Healthcare Services
Patient Square Capital, a healthcare-focused private equity firm, has completed the acquisition of Patterson Companies for $31.35 per share (transaction value approximately $4.1 billion). The deal closed April 17, 2025, taking Patterson private; Robert Rajalingam was named CEO and Patterson will continue to be headquartered in St. Paul, Minnesota.
-
Patient Square Capital Acquires Premier, Inc.
November 25, 2025
Healthcare Services
Patient Square Capital, a healthcare-focused investment firm, has completed its $2.6 billion acquisition of Premier, Inc. Under the deal, Premier will be taken private, delisted from Nasdaq, and Premier stockholders will receive $28.25 per share in cash. The transaction positions Patient Square to grow Premier's technology-driven data, analytics, supply chain and consulting offerings.
-
Patient Square Capital Acquires SOC Telemed, Inc.
February 3, 2022
Healthcare Services
Patient Square Capital agreed to acquire SOC Telemed, Inc., the largest U.S. provider of acute care telemedicine, in an all-cash transaction valuing SOC Telemed at $3.00 per share. The deal takes SOC Telemed private and will provide capital and industry expertise to expand the company’s clinical capabilities, innovate its Telemed IQ platform and grow its footprint across hospitals, post-acute and value-based care organizations.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.